These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20512645)

  • 1. Structural modeling of high-affinity thyroid receptor-ligand complexes.
    de Araujo AS; Martínez L; de Paula Nicoluci R; Skaf MS; Polikarpov I
    Eur Biophys J; 2010 Oct; 39(11):1523-36. PubMed ID: 20512645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Only subtle protein conformational adaptations are required for ligand binding to thyroid hormone receptors: simulations using a novel multipoint steered molecular dynamics approach.
    Martínez L; Polikarpov I; Skaf MS
    J Phys Chem B; 2008 Aug; 112(34):10741-51. PubMed ID: 18681473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based approach for the study of thyroid hormone receptor binding affinity and subtype selectivity.
    Wang FF; Yang W; Shi YH; Cheng XR; Le GW
    J Biomol Struct Dyn; 2016 Oct; 34(10):2251-67. PubMed ID: 26510472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling revealed that ligand dissociation from thyroid hormone receptors is affected by receptor heterodimerization.
    Zhuang S; Bao L; Linhananta A; Liu W
    J Mol Graph Model; 2013 Jul; 44():155-60. PubMed ID: 23831995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the denaturation mechanisms of the ligand binding domain of thyroid hormone receptors.
    Martínez L; Souza PC; Garcia W; Batista FA; Portugal RV; Nascimento AS; Nakahira M; Lima LM; Polikarpov I; Skaf MS
    J Phys Chem B; 2010 Jan; 114(3):1529-40. PubMed ID: 20043653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor.
    Chiellini G; Apriletti JW; Yoshihara HA; Baxter JD; Ribeiro RC; Scanlan TS
    Chem Biol; 1998 Jun; 5(6):299-306. PubMed ID: 9653548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new hormone-binding site on the surface of thyroid hormone receptor.
    Souza PC; Puhl AC; Martínez L; Aparício R; Nascimento AS; Figueira AC; Nguyen P; Webb P; Skaf MS; Polikarpov I
    Mol Endocrinol; 2014 Apr; 28(4):534-45. PubMed ID: 24552590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptor.
    Jeyakumar M; Webb P; Baxter JD; Scanlan TS; Katzenellenbogen JA
    Biochemistry; 2008 Jul; 47(28):7465-76. PubMed ID: 18558711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of agonist and antagonist effects on thyroid hormone receptor conformation by hydrogen/deuterium exchange.
    Figueira AC; Saidemberg DM; Souza PC; Martínez L; Scanlan TS; Baxter JD; Skaf MS; Palma MS; Webb P; Polikarpov I
    Mol Endocrinol; 2011 Jan; 25(1):15-31. PubMed ID: 21106879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and structural biology of thyroid hormone receptors.
    Apriletti JW; Ribeiro RC; Wagner RL; Feng W; Webb P; Kushner PJ; West BL; Nilsson S; Scanlan TS; Fletterick RJ; Baxter JD
    Clin Exp Pharmacol Physiol Suppl; 1998 Nov; 25():S2-11. PubMed ID: 9809185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study for the binding affinity of thyroid hormone receptors based on machine learning algorithm.
    Li N; Cai R; Guan R; Wang W; Liu W; Zhao C
    SAR QSAR Environ Res; 2022 Aug; 33(8):601-620. PubMed ID: 35924759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-specific anti-thyroid hormone receptor (TR) antibodies detect changes in TR structure due to ligand-binding and dimerization.
    Yen PM; Sugawara A; Forgione M; Spanjaard RA; Macchia E; Cheng SY; Chin WW
    Mol Cell Endocrinol; 1993 Nov; 97(1-2):93-9. PubMed ID: 7511545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.
    Martínez L; Sonoda MT; Webb P; Baxter JD; Skaf MS; Polikarpov I
    Biophys J; 2005 Sep; 89(3):2011-23. PubMed ID: 15980170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative ligands for thyroid hormone receptors.
    Lazcano I; Hernández-Puga G; Robles JP; Orozco A
    Mol Cell Endocrinol; 2019 Aug; 493():110448. PubMed ID: 31100496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helix 12 dynamics and thyroid hormone receptor activity: experimental and molecular dynamics studies of Ile280 mutants.
    Souza PC; Barra GB; Velasco LF; Ribeiro IC; Simeoni LA; Togashi M; Webb P; Neves FA; Skaf MS; Martínez L; Polikarpov I
    J Mol Biol; 2011 Oct; 412(5):882-93. PubMed ID: 21530542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Possible Novel Mechanism of Action of Genistein and Daidzein for Activating Thyroid Hormone Receptor-Mediated Transcription.
    Ariyani W; Iwasaki T; Miyazaki W; Yu L; Takeda S; Koibuchi N
    Toxicol Sci; 2018 Aug; 164(2):417-427. PubMed ID: 29688519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function.
    Nascimento AS; Dias SM; Nunes FM; Aparício R; Ambrosio AL; Bleicher L; Figueira AC; Santos MA; de Oliveira Neto M; Fischer H; Togashi M; Craievich AF; Garratt RC; Baxter JD; Webb P; Polikarpov I
    J Mol Biol; 2006 Jul; 360(3):586-98. PubMed ID: 16781732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of ligand affinity to the contact dynamics of the ligand binding domain of thyroid hormone receptor - retinoid X receptor.
    Lim JPL; Braza MKE; Nellas RB
    J Mol Graph Model; 2021 May; 104():107829. PubMed ID: 33450664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
    Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
    Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.